Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2020-07-15

Clinical Trial Update: Fecal Microbiota Transplantation by Colonoscopy for Recurrent C. Difficile Infection [Phase 2]

View source ↗

Summary

Phase 2 trial studying fecal microbiota transplantation via colonoscopy for recurrent Clostridium difficile infection has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Fecal microbiota transplantation (fecal microbiota transplantation)

Snippet

Sponsor: Catholic University of the Sacred Heart | Conditions: Clostridium Difficile | Phase 2 | Status: COMPLETED